Antithesis Ventures Fund I GP LLC vs Annual Series GP Ulc

Antithesis Ventures Fund I GP LLC vs Annual Series GP Ulc Overbay 2026 Fund

Antithesis Ventures Fund I GP LLC is a venture capital based in Washington, DC. Annual Series GP Ulc Overbay 2026 Fund is a venture capital based in Toronto across 1,800 portfolio companies. Sector focus diverges: Antithesis Ventures Fund I GP LLC concentrates on generalist deals and Annual Series GP Ulc Overbay 2026 Fund on Artificial Intelligence, Crypto Web3 and Fintech.

• Investor type: Antithesis Ventures Fund I GP LLC — Venture Capital; Annual Series GP Ulc Overbay 2026 Fund — Venture Capital
• Headquarters: Antithesis Ventures Fund I GP LLC — Washington, DC; Annual Series GP Ulc Overbay 2026 Fund — Toronto
• Portfolio companies: Antithesis Ventures Fund I GP LLC — not disclosed; Annual Series GP Ulc Overbay 2026 Fund — 1,800
• Sectors: Antithesis Ventures Fund I GP LLC — not disclosed; Annual Series GP Ulc Overbay 2026 Fund — Artificial Intelligence, Crypto Web3, Fintech

• Antithesis Ventures Fund I GP LLC — Venture Capital · Washington, DC · Antithesis Ventures Fund I GP LLC portfolio
• Annual Series GP ULC Overbay 2026 Fund — Venture Capital · Toronto · 1,800 tracked deals · Annual Series GP Ulc Overbay 2026 Fund portfolio

Similar investors

• Pete Mathias
• Michael Collins
• Roy Glasberg
• Private Credit Fund I GP, LP Dynamic
• Nimble Partners, LLC
• Edward Tsai
• Jordan Stein
• Aaron Vermut
• Wellington Funds (US) LLC
• Nimble Partners GP, LLC

Investors like Antithesis Ventures Fund I GP LLC · Investors like Annual Series GP Ulc Overbay 2026 Fund · Antithesis Ventures Fund I GP LLC co-investors · Full investor directory